The seafood industry is facing unprecedented challenges (WAFIC 2020 Strategy, FRDC R&D 2015).
The networks established by CESSH have laid a strong foundation to attract national and international
investment partners. For the first time, the whole industry along the supply chain and post harvest is
working together to achieve outcomes that benefit the WA (and national seafood industry) and the
health of the Australian population. It is essential that the industry is able to remain viable and indeed
grow, within the constraints of an ever changing economic, technological and food security landscape.
There is a need for a continued go-to place that the industry can access to gain support to develop
new products, investigate novel and improved means of harvest, reduce production costs and provide
evidence of the value of consuming seafood. CESSH needs to build on existing strong capacity areas
and establish expertise in areas that are currently not available in WA to service the growing and
diverse needs of industry. This could afford industry a point of difference in the provision of world class
support to answer research and science questions that impact on growth, quality or profitability in a
timely fashion, an essential service for a primary industry.
Report
For each processing waste case study, an individual report summarising the methods and results was produced and provided to the industry partners as well as generally being made available as publishable appendices to this report. Some of the outcomes were for non-human products such as Patagonian Toothfish, tuna and other finfish hydrolsate for fertiliser, aquaculture feed or pet food, composting products, low quality oil and extracted enzymes for potential addition to detergents. However there were also some high value food products produced including scampi roe, Blue Mussel stock, pearl meat adductor muscle and fish maw (swim bladders). In total, of the eleven industry requested case studies commenced three new products have been commercialised (tuna hydrolysate, scampi roe and pearl adductor muscle), and a number of other products are in market/commercial trials.